Background: Unprotected sexual intercourse is the most common mode of HIV-1 transmission being semen the most important vector for this infection. Dendritic cells (DCs) are abundantly located on mucosal surfaces and play different roles during HIV infection: promote HIV spread by boosting CD4 + T cell infection and activate the HIV specific adaptive immune response. As semen has been shown to promote immune tolerance in different models, we hypothesize that components present in plasma seminal (SP) might modulate DC function promoting a tolerogenic immune response. To test this, we study the ability of complete SP to modulate DC function and the ability of these cells to induce CD25 + /FOXP3 + regulatory T cells. Methods: SP was obtained from healthy donors. Monocyte derived DCs were cultured during 24 hs with SP samples (diluted 1/ 100) in the absence or presence of LPS (10ng/ml). DC phenotype was studied by flow cytometry. Cytokine secretion was measured in culture supernatants by ELISA. After SP treatment, DCs were cultured with allogeneic CD4 + T cells and the induction of CD25 + /FOXP3 + T cells was analyzed by flow cytometry. Results: We found that SP inhibited IL-12, IL-6, TNF-alpha and IL-1, but not IL-10 production by LPS stimulated DCs (percent of inhibition respect to LPS alone: 81.2 + / -11.07% p < 0.0001 for IL-12, 43.45 + / -2.87% p < 0.001 for IL-6, 69.8 + / -17.31% p < 0.001 for TNF-alpha, 37.5 + / -13.15% p < 0.05 for IL-1, 6.1 + / -15.6% p = 0.6 for IL-10). SP also boosted the ability of LPS stimulated DCs to induce CD25 + /FOXP3 + T cells (PS + LPS = 20,4% vs LPS alone = 6%, p < 0,05). We observed no changes on the expression of HLA-DR, CD80, CD86, CD83, CD40 and CD1a on immature or LPS-maturated DCs after incubation with SP. Conclusions: SP modulates DC function, inhibiting the secretion of pro-inflammatory cytokines and favoring the induction of CD25 + /FOXP3 + T cells. In this way, we speculate that SP might modulate the adaptive immune response against sexual transmitted pathogens.
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In Vivo Viral Control in a HLA-B Background: Virus-specific CD8 T cell responses to epitopes restricted by HLA-B*35:01 are generally believed to be ineffective in mediating in vivo control of HIV infection. We report a case of a patient homozygous for HLA-B*35:01 who showed successful viral control after vaccination with MVA-B vaccine combined with a drug to reactivate HIV-1 replication (disulfiram), and who subsequently underwent an analytical treatment interruption (ATI). Methods: Therapeutic vaccination consisted of 3 intramuscular injections of MVA-B at 0,4,16 weeks and a 4th dose followed by 2 months of disulfiram. cART was discontinued 8 weeks after last vaccination. IFN-c ELISPOT was used to assess immunogenicity and proviral reservoir was determined over time. Viral rebound dynamics were assessed during ATI. Results: The patient had a past history of high viral load set point (362,000 copies/ml) and cART was initiated during chronic infection. After ATI the patient remained with low level viral load < 200 copies/ml for > 24 weeks without showing a significant decay in CD4 T-cell counts. At baseline, the patient showed a broad (19 different specificities) and strong (9,189 SFC/10 
